Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A

Microbiol Immunol. 2006;50(9):707-11. doi: 10.1111/j.1348-0421.2006.tb03843.x.

Abstract

A real-time PCR assay with the cycling probe method was used to detect mutations at codons 83 and 87 in the DNA gyrase A subunit encoded by gyrA in Salmonella enterica serovar Typhi and Paratyphi A clinical isolates. The susceptibility estimated from the results of the gyrA mutation assay was consistent with that identified by the culture method using an E-test. This assay allows rapid screening of S. enterica serovar Typhi and Paratyphi A with reduced susceptibility to ciprofloxacin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Ciprofloxacin / pharmacology*
  • DNA Gyrase / genetics*
  • Drug Resistance, Bacterial
  • Humans
  • Mutation
  • Paratyphoid Fever / microbiology
  • Polymerase Chain Reaction / methods*
  • Salmonella paratyphi A / drug effects*
  • Salmonella paratyphi A / genetics
  • Salmonella typhi / drug effects*
  • Salmonella typhi / genetics
  • Typhoid Fever / microbiology

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • DNA Gyrase